supported by the start-up funds from New York University Abu Dhabi;partially carried out using the Core Technology Platforms resources at New York University Abu Dhabi。
Tunneling wounds create passageways underneath the skin surface with varying sizes and shapes and can have twists and turns,making their treatment extremely difficult.Available wound care solutions only cater to super...
supported by the National Natural Science Foundation of China(No.U2004119);Major Science and Technology Projects in Henan Province(No.221100310100);the Henan Province Medical Science and Technology Public Relations Plan Province Department joint construction project(No.SBGJ202102100).
This randomized,prospective,multicenter(12 centers in China)phase III trial(Chinese Clinical Trial Registry#ChiCTR2000041170)compared drug-eluting bead transarterial chemoembolization(DEB-TACE)combined with apatinib a...
Supported by Mianyang Health Commission 2019 Scientific Research Encouragement Project,No.201948.
BACKGROUND The combination of acute ST-segment elevation myocardial infarction(STEMI)and gastric ulcers poses a challenge to primary percutaneous coronary intervention(PPCI),particularly for young patients.The role of...
support for this work from the National Natural Science Foundation of China,China (52173127).
Zinc(Zn)alloys have demonstrated significant potential in healing critical-sized bone defects.However,the clinical application of Zn alloys implants is still hindered by challenges including excessive release of zinc ...
Supported by Project of Medical and Health Technology Program in Zhejiang Province,No.2020KY787.
BACKGROUND The objectives of this study were to assess the safety and efficacy of drug-eluting bead transarterial chemoembolization(DEB-TACE)as neoadjuvant therapy before liver transplantation(LT)for advanced-stage he...
BACKGROUND In severe cases of coronary artery disease,percutaneous coronary intervention provide promising results.The stent used could be a drug-eluting stent(DES)or a titanium-nitride-oxide coated stent(TiNOS).AIM T...
National Natural Science Foundation of China(11932014,31971239);Sichuan Science and Technology Program(2022NSFSC0765,2022ZYD0079).
The limitations of current drug-eluting stent technologies in selectively inhibiting vascular smooth muscle cell proliferation,which often leads to inflammation,call for innovative approaches in coronary artery diseas...
BACKGROUND Percutaneous drug-eluting stent implantation(DESI)is an emerging and promising treatment modality for infrapopliteal artery diseases(IPADs).This systematic review and meta-analysis summarizes and quantitati...
This work was supported by the National Key Research and Development Program of China(Grant numbers 2020YFE0204400);National Natural Science Foundation of China(Grant numbers 82271063,82271064,52203190,82070939,and 22005265);Key Research and Development Project of Zhejiang Province(Grant number 2020C03035);Postdoctoral Science Foundation of China(Grant number 2020TQ0261);Fundamental Research Funds for the Central Universities(Grant number 2021FZZX003-01-03).
Posterior capsule opacification(PCO)is the most common long-term postoperative complication of cataract surgery,leading to secondary vision loss.Optimized intraocular lens(IOL)structure and appropriate pharmacological...
Objective::Data comparing the outcomes of MiStent(Micell Technologies,Durham,North Carolina,USA)microcrystalline biodegradable polymer(BP)drug-eluting stent(DES)and those of another post-marketing BP-DES,TIVOLI(EssenT...